Clearbridge Health Limited Stock Price
Last Done:
SGD 9.39
+0.12 (+1.31%)
• Login required for live price
Open: --
High: --
Low: --
Prev Close: --
Login to unlock live stock price, change %, and intraday data.
Login to View
📊 Statistics
- Analyst 1 Year Price Target:
-
- Upside/Downside from Analyst Target:
-
- Broker Call:
-
- Dividend Minimum 3 Year Yield:
0.00%
- EPS Growth Range (1Y):
50-100%
- Net Income Growth Range (1Y):
50-100%
- Revenue Growth Range (1Y):
<0%
-
Upcoming Earnings Date:
-
💰 Dividend History
Current year to date yield:
0.00%
Amount: -
Yield: -
Pay Date: -
Details:
Ratio: 2:1
📅 SGX Earnings Announcements for 1H3
Clearbridge Health Limited (1H3)
Market: SGX |
Currency: SGD
Address: 37 Jalan Pemimpin
Clearbridge Health Limited, an investment holding company, provides healthcare solutions in Singapore, the Philippines, Hong Kong, Malaysia, and internationally. It operates through Strategic Investments, Healthcare Systems, and Medical Clinics/Centres segments. The company provides imaging services, including general x-ray, computerized tomography scan, dental cone beam CT scan, mammography, magnetic resonance imaging, and ultrasound; general health services, such as diabetes, high blood pressure, and high cholesterol screening; and vaccination services, as well as renal care and clinical services. It also offers aesthetics, and dental and orthodontics services, as well as consultancy services for healthcare organization; and wholesales medicinal and pharmaceutical products. Clearbridge Health Limited was incorporated in 2010 and is based in Singapore.
Show more
📈 Clearbridge Health Limited Historical Chart
🧾 Recent Financial Statement / Corporate annoucement / News
March 12, 2026
Clearbridge Health Limited: Detailed Analysis of SGX Query Responses and Potential Price-Sensitive Issues Clearbridge Health Limited Responds to SGX Queries on FY2025 Results: Key Issues and Investor Implications Executive Summary Clearbridge Health Limited has issued responses to queries from the…
February 28, 2026
Clearbridge Health Limited Announces Structural Changes and Subsidiary Updates Clearbridge Health Limited, a healthcare company listed on the Singapore Exchange Catalist Board, has released an update detailing significant structural changes within its group for the six-month period from 1 July…
February 28, 2026
Clearbridge Health Limited: FY2025 Financial Analysis & Investor Outlook Clearbridge Health Limited released its unaudited condensed interim financial statements for the six months (H2) and full financial year (FY) ended 31 December 2025. This review provides a structured analysis of…
February 23, 2026
Clearbridge Health Limited: FY2025 Profit Guidance and Financial Outlook Clearbridge Health Limited has released a profit guidance for the financial year ended 31 December 2025. The announcement signals a challenging period for the company, with a significantly higher net loss…
January 23, 2026
Clearbridge Health Limited: Lapse of Term Sheet for Proposed Acquisition of Elpis Biopharmaceuticals Clearbridge Health Limited Announces Lapse of Term Sheet for Proposed Acquisition of Elpis Biopharmaceuticals Key Highlights for Investors Lapse of Acquisition Term Sheet: Clearbridge Health Limited (“the…
December 11, 2024
Clearbridge Health's Major Share Expansion: What Investors Need to Know Clearbridge Health's Major Share Expansion: What Investors Need to Know Clearbridge Health Limited has announced a significant development in its capital structure through a renounceable non-underwritten rights issue. The company…
December 11, 2024
Clearbridge Health's Strategic Rights Issue: A Financial Game-Changer Clearbridge Health's Strategic Rights Issue: A Financial Game-Changer Clearbridge Health Limited is making a bold move with its recent announcement of a Rights Issue, which could significantly impact its share price and…
November 20, 2024
Clearbridge Health Limited Financial Analysis - Q3FY24 Clearbridge Health Limited Financial Analysis - Q3FY24 Business Description Clearbridge Health Limited is incorporated in the Republic of Singapore. The company, along with its subsidiaries, operates in the healthcare sector focusing on providing…
November 19, 2024
Clearbridge Health's Rights Issue: Strategic Move or Risky Bet? Clearbridge Health's Rights Issue: Strategic Move or Risky Bet? Clearbridge Health Limited has announced a rights issue, aiming to raise up to S\$2,308,000. This move is designed to bolster the company's…
🔎 View more in SGX corporate News 🔎 View more in SGX Financial statements
📰 Research Reports
usort($results_posts, function($a, $b) {
return get_post_time('U', true, $b) - get_post_time('U', true, $a);
});
?>
No related articles found.
